Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 6, 2026 · Filed Nov 10, 2026
A major shareholder of Boundless Bio paid $4.1K out of pocket for Boundless Bio shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$4,080
Shares × reported transaction price
<$25K
First purchase in 0 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 33 earlier confirmed purchases
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
Closed at $2.46 on Nov 6, 2026, 134% above its 52-week low and 18% below its high, after an 8% drop over the previous 30 trading days
52-week range $1.05 (Feb 4, 2026) to $3.00 (Aug 21, 2026), 72% of the way up, from 251 adjusted closes. 30 trading days earlier: $2.66 on Sep 25, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
Insider buying
Traded Nov 10 · filed the same day
A major shareholder of Boundless Bio paid $598 out of pocket for Boundless Bio shares.
Insider buying
Traded Nov 4 · filed 1 day later
A major shareholder of Boundless Bio paid $1.2K out of pocket for Boundless Bio shares.
Insider buying
Traded Nov 5 · filed the same day
A major shareholder of Boundless Bio paid $20K out of pocket for Boundless Bio shares.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
TANG KEVIN, 10% owner's past purchases, 90 days after disclosure: 9 buys, median +0.2 pts vs S&P 500, beat it 5 of 9 times. Past results, not a forecast.